AXNX News and Press, Axonics Modulation Technologies Inc. From 05/06/21

Axonics Modulation Technologies (AXNX): Q1 GAAP EPS of -$0.57 misses by $0.17.Revenue of $34.4M (+30.8% Y/Y) beats by $6.47M.Axonics anticipates fiscal year 2021 net revenue to be in the range of $176 million to $180 million vs. consensus of $169.90M, which would represent growth of approxima...

Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today reported financial results for the first quarter ended March 31, 2021. “This quarter’s reve...

Top-rated stocks in our research that also have a strong track record of beating analyst expectations. Stock ideas cutting across most sectors. Over 50 ideas worth considering for watch lists. For further details see: Stocks With The Best History Of Beating Estimates

Axonics Inc. (NASDAQ:AXNX) traded today at a new 52-week high of $63.50. So far today approximately 153,000 shares have been exchanged, as compared to an average 30-day volume of 487,000 shares. Based on a current price of $63.20, Axonics Inc. is currently 7.3% above its average consensu...

Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that has developed and is commercializing novel products for the treatment of bladder and bowel dysfunction, is scheduled to participate in the BofA Securities 2021 Virtual Healthcare Conference on Thursday, May 13, 2021....

Axonics Inc. (NASDAQ:AXNX) traded at a new 52-week high today of $61.61. So far today approximately 153,000 shares have been exchanged, as compared to an average 30-day volume of 483,000 shares. Axonics Inc is a United stated based medical technology company. It focuses on the design, de...

Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that has developed and is commercializing novel products for the treatment of bladder and bowel dysfunction, will report first quarter 2021 financial results after the market closes on Thursday, May 6, 2021. In conjun...

Axonics Modulation Technologies, Inc. (Nasdaq: AXNX), a global medical technology company that has developed and is commercializing novel products for the treatment of bladder and bowel dysfunction, is scheduled to participate in the virtual Barclays Global Healthcare Conference on Marc...

Endotronix Appoints Industry Veteran Dan Dearen to Board of Directors Expands company's financial expertise during time of growth in advance of commercial launch PR Newswire LISLE, Ill. , March 2, 2021 /PRNewswire/ -- Endotronix, Inc., a digital health and me...

Axonics Modulation Technologies (AXNX) has entered into a strategic alliance with Micro Systems Technologies ((MST)). This strategic alliance expands Axonics’ relationship with MST, with the parties collaborating on the non-rechargeable implantable sacral neuromodulation ((SNM)) d...